Updated 04:01 GMT, 8 Nov 2026 SPX 7,376.86 +0.31% NDX 26,989.99 +1.35% VIX 25.64 -9.01% GOLD 4,074.90 -0.94% CL 90.83 +0.34% BTC 75,817.70 +0.09%
NAS100 26,990 +1.35% S&P 7,377 +0.31% GOLD $4,075 −0.94% BTC $75,818 +0.09% VIX 25.64 −9.01% latest tape · as of 04:01 UTC
The Screen · Technology · Software - Infrastructure

The Glimpse Group, Inc.

GGRP · Nasdaq · USD · Market cap $20M · 40 employees

The Glimpse Group, Inc., an immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

FAIL · Does not pass the screen
0.93 USD

Price as of 14 Oct 2026Daily close, not a live quoteLast reviewed 25 days ago

Screened 2026-10-14 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price0.93 USD at the 14 Oct 2026 close
  • Our regime readMarkup, as of 8 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed14 Oct 2026 (25 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-10-14).

Current read
Markup ?
Screened · screened 2026-10-14
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price0.93 USD
Ethical score88.6/100
Our investment reviews on this name
2026-07-02Read Markup0.79+18.6% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

The Glimpse Group, Inc. holds its Markup at $0.93. The statistical read favours the buyers, held for 19 days.

As held on the ledger · 2026-10-14
PhaseMarkup
Quantitative stateThe statistical read favours the buyers, held for 19 days
Price at the screen$0.93
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 88.6
Beta1.37
The Workings

Five Screens, Shown in Full

Does not pass. Interest/revenue 44.6%

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 1.70% Below 33% Interest-bearing debt is just 1.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 28.32% Below 33% Cash held in interest-bearing accounts and securities is 28.3% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 44.60% Below 5% 44.6% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

The Glimpse Group, does not pass the ethical screen. The binding factor is interest/revenue 44.6%.

Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.

2026-10-25 Does not pass

The Glimpse Group, does not pass the ethical screen. The binding factor is interest/revenue 44.6%.

2026-09-24 Clears

The Glimpse Group, clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

Follow this verdict

Get an email when GGRP's ethical verdict changes

Today GGRP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
EPS, trailing-0.70
Revenue growth-53.8%revenue is shrinking
Profit margin-218.9%currently unprofitable
Return on equity-154.4%not currently earning a positive return on equity
FCF yield-17.80%
Debt to equity0.06minimal debt: a conservative balance sheet
Current ratio3.42comfortably covers its short-term bills
Beta1.37moves a little more than the market
Short interest, float0.02%
52-week range0.42 - 1.85
Market cap$20M
Employees40

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

GGRP trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-30 Markup $0.93 +0.0% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-10-18 Markup $0.93 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-10-02 Markup $0.93 +0.0% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-08-30 Markup $0.93 +18.6% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-07-31 Markup $0.79 0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-07-18 Markup $0.79 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 47%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it none, with a mean price target of $3.

2026-07-03 Markup $0.79 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markup $0.79 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on GGRP

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in GGRP's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · GGRP
DateInsiderTitleTypeSharesValue
2025-12-18 BENTOVIM LYRON L Chief Executive Officer 3,172 $3,109
2024-12-11 BENTOVIM LYRON L Chief Executive Officer 10,634 $15,951

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.51 +54.3% · $1,543 +54.3%
2 months $0.51 +52.2% · $1,522 +52.2%
3 months $0.64 +22.2% · $1,222 +22.2%
6 months $1.08 -27.7% · $723 -27.7%
1 year $1.47 -46.9% · $531 -46.9%
2 years $1.13 -30.9% · $691 -30.9%
3 years $3.97 -80.3% · $197 -80.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever GGRP does next, these words stay.

The Glimpse Group, Inc. · GGRP · Markup · $0.93
Recorded 2026-10-14 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.